Matches in Wikidata for { <http://www.wikidata.org/entity/Q92853718> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q92853718 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92853718 description "im August 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92853718 description "scientific article published on 22 August 2019" @default.
- Q92853718 description "wetenschappelijk artikel" @default.
- Q92853718 description "наукова стаття, опублікована 22 серпня 2019" @default.
- Q92853718 name "Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial" @default.
- Q92853718 name "Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial" @default.
- Q92853718 type Item @default.
- Q92853718 label "Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial" @default.
- Q92853718 label "Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial" @default.
- Q92853718 prefLabel "Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial" @default.
- Q92853718 prefLabel "Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial" @default.
- Q92853718 P1433 Q92853718-378EB750-EADF-4332-BC21-82B1B97A2C98 @default.
- Q92853718 P1476 Q92853718-F90956A4-E844-497C-BAB4-5F7FB962BFED @default.
- Q92853718 P2093 Q92853718-3AC0A2C4-A5D5-4A20-ABED-12B500188396 @default.
- Q92853718 P2093 Q92853718-49C919FD-4D2C-4366-82BE-B2DC8ED768BD @default.
- Q92853718 P2093 Q92853718-4DB72896-0F23-4952-8A16-6B1E30B9C973 @default.
- Q92853718 P2093 Q92853718-5F1E39A9-6684-4769-B577-91D2136C5B60 @default.
- Q92853718 P2093 Q92853718-65E551F5-0D81-4422-AC6B-A9C2B3A0DADE @default.
- Q92853718 P2093 Q92853718-6B1F8ADF-CA7D-4FA4-A884-5AC453233DCC @default.
- Q92853718 P2093 Q92853718-780D06B4-A154-4FF8-814B-D0FCE52FD048 @default.
- Q92853718 P2093 Q92853718-7F7F1EB2-02B9-4699-80E0-981B0880C3C5 @default.
- Q92853718 P2093 Q92853718-A05EBCFE-CA9A-4392-AA4C-23F8A939020F @default.
- Q92853718 P2093 Q92853718-B875F782-966A-4CC9-97CB-C6FF222B93E2 @default.
- Q92853718 P2093 Q92853718-BBEB95C6-7B98-4E43-AC4D-A964DFB56723 @default.
- Q92853718 P304 Q92853718-EB68A744-43EC-4068-9481-09B351FF001E @default.
- Q92853718 P31 Q92853718-BB509402-5909-4CA1-B248-F0B1078FBD3B @default.
- Q92853718 P356 Q92853718-28A8F99B-C26F-4C46-B7F8-4BAA872BA793 @default.
- Q92853718 P433 Q92853718-2E1A71D7-239A-4DD4-99CB-3F827107D7DC @default.
- Q92853718 P478 Q92853718-962EDD43-BECB-4598-9999-090497885797 @default.
- Q92853718 P577 Q92853718-ECB4A457-C434-4E7F-8611-8BE36A1D7AE3 @default.
- Q92853718 P698 Q92853718-A298AC04-A071-4AA1-A890-48FE8962E60C @default.
- Q92853718 P356 J.CLINTHERA.2019.06.012 @default.
- Q92853718 P698 31447131 @default.
- Q92853718 P1433 Q15716601 @default.
- Q92853718 P1476 "Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial" @default.
- Q92853718 P2093 "Elsa Valdes-Marquez" @default.
- Q92853718 P2093 "Fang Chen" @default.
- Q92853718 P2093 "HPS2-THRIVE Collaborative Group" @default.
- Q92853718 P2093 "HPS2-THRIVE Steering Committee members" @default.
- Q92853718 P2093 "HPS2-THRIVE Writing Committee members" @default.
- Q92853718 P2093 "Jane Armitage" @default.
- Q92853718 P2093 "Jemma C Hopewell" @default.
- Q92853718 P2093 "Jing Li" @default.
- Q92853718 P2093 "Martin J Landray" @default.
- Q92853718 P2093 "Richard Haynes" @default.
- Q92853718 P2093 "Sarah Parish" @default.
- Q92853718 P304 "1767-1777" @default.
- Q92853718 P31 Q13442814 @default.
- Q92853718 P356 "10.1016/J.CLINTHERA.2019.06.012" @default.
- Q92853718 P433 "9" @default.
- Q92853718 P478 "41" @default.
- Q92853718 P577 "2019-08-22T00:00:00Z" @default.
- Q92853718 P698 "31447131" @default.